Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 30-Sep 2021. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
4635638010 | Levocloperastine fendizoate | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
4635639019 | Levocloperastine fendizoate (substance) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Levocloperastine fendizoate | Is a | Piperidine | true | Inferred relationship | Some | ||
Levocloperastine fendizoate | Is a | Antitussive agent (substance) | true | Inferred relationship | Some | ||
Levocloperastine fendizoate | This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. | Levocloperastine (substance) | true | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Levocloperastine fendizoate 7.08 mg/mL oral suspension | The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). | True | Levocloperastine fendizoate | Inferred relationship | Some | 1 |
Levocloperastine fendizoate 7.08 mg/mL oral suspension | This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. | True | Levocloperastine fendizoate | Inferred relationship | Some | 1 |
This concept is not in any reference sets